Coronavirus disease 2019: coronaviruses and blood safety
L Chang, Y Yan, L Wang - Transfusion medicine reviews, 2020 - Elsevier
With the outbreak of unknown pneumonia in Wuhan, China, in December 2019, a new
coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), aroused …
coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), aroused …
Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
The ongoing pandemic coronavirus disease 19 (COVID-19) caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is a matter of global concern …
respiratory syndrome coronavirus 2 (SARS-CoV-2) is a matter of global concern …
Convalescent plasma therapy for COVID-19: state of the art
Convalescent plasma (CP) therapy has been used since the early 1900s to treat emerging
infectious diseases; its efficacy was later associated with the evidence that polyclonal …
infectious diseases; its efficacy was later associated with the evidence that polyclonal …
Coronavirus seasonality, respiratory infections and weather
Background The survival of coronaviruses are influenced by weather conditions and
seasonal coronaviruses are more common in winter months. We examine the seasonality of …
seasonal coronaviruses are more common in winter months. We examine the seasonality of …
A Systematic Review of therapeutic agents for the treatment of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
H Momattin, AY Al-Ali, JA Al-Tawfiq - Travel medicine and infectious …, 2019 - Elsevier
Abstract Background The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) was
first described in 2012 and attracted a great international attention due to multiple healthcare …
first described in 2012 and attracted a great international attention due to multiple healthcare …
A systematic review of emerging human coronavirus (SARS-CoV-2) outbreak: focus on disinfection methods, environmental survival, and control and prevention …
Z Noorimotlagh, SA Mirzaee, N Jaafarzadeh… - … Science and Pollution …, 2021 - Springer
Recently, an outbreak of a novel human coronavirus which is referred to as severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2)(COVID-19) by the World Health …
respiratory syndrome coronavirus 2 (SARS-CoV-2)(COVID-19) by the World Health …
Control measures for SARS-CoV-2: a review on light-based inactivation of single-stranded RNA viruses
J Hadi, M Dunowska, S Wu, G Brightwell - Pathogens, 2020 - mdpi.com
SARS-CoV-2 is a single-stranded RNA virus classified in the family Coronaviridae. In this
review, we summarize the literature on light-based (UV, blue, and red lights) sanitization …
review, we summarize the literature on light-based (UV, blue, and red lights) sanitization …
[HTML][HTML] Is SARS‐CoV‐2 transfusion transmitted?
LM Katz - Transfusion, 2020 - ncbi.nlm.nih.gov
Anumber of published studies report that the RNA of SARS-CoV-2, the virus causing
pandemic COVID-19, is detected in the blood, plasma, or serum of infected people. 1–3 …
pandemic COVID-19, is detected in the blood, plasma, or serum of infected people. 1–3 …
IT applications in healthcare management: a survey
M Yamin - International Journal of Information Technology, 2018 - Springer
Healthcare management is currently undergoing substantial changes, and reshaping our
perception of the medical field. One spectrum is that of the considerable changes that we …
perception of the medical field. One spectrum is that of the considerable changes that we …
Inactivation of a broad spectrum of viruses and parasites by photochemical treatment of plasma and platelets using amotosalen and ultraviolet A light
MC Lanteri, F Santa‐Maria, A Laughhunn… - …, 2020 - Wiley Online Library
BACKGROUND The INTERCEPT Blood System pathogen reduction technology (PRT),
which uses amotosalen and ultraviolet A light treatment (amotosalen/UV‐PRT), inactivates …
which uses amotosalen and ultraviolet A light treatment (amotosalen/UV‐PRT), inactivates …